Skip to content

MEDICINES CO /DE

Delisted

CIK 1113481fmd_0ZD4M8AEM1WF10F63SXA27YGAGManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2019, 44 periods

Latest annual · FY2018

Millions
Total revenues
6
Gross profit
(1)
Operating income
(191)
Net income
(123)
Free cash flow
(262)

Latest quarter · Q3 FY2019

Millions
Total revenues
0
Gross profit
0
Operating income
(61)
Net income
(74)
Free cash flow
(61)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
-72.5%
Revenue, 5 yearsFY2013 to FY2018
-60.3%
Net income, 5 yearsFY2013 to FY2018
n/m

MEDICINES CO /DE financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$6.1 million$44.8 million-86.3%10-K 2019-02-27 · proof
Gross profit-$1.1 million-$2.4 million10-K 2019-02-27 · proof
Operating income-$191.4 million-$665.1 million10-K 2019-02-27 · proof
Net income-$123.2 million-$708.4 million10-K 2019-02-27 · proof
Cash from operating activities-$261.8 million-$368.3 million10-K 2019-02-27 · proof
Free cash flow-$261.8 million-$372.8 million10-K 2019-02-27 · proof
Total assets$841.7 million$873 million-3.6%10-K 2019-02-27 · proof
Total liabilities$864 million$848.1 million+1.9%10-K 2019-02-27 · proof
Cash and cash equivalents$238.3 million$151.4 million+57.4%10-K 2019-02-27 · proof
What was MEDICINES CO /DE's revenue in fiscal 2018?
MEDICINES CO /DE reported revenue of $6.1 million for fiscal 2018 (the year ended Dec 31, 2018), against $44.8 million the year before (-86.3%). Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What was MEDICINES CO /DE's gross profit in fiscal 2018?
MEDICINES CO /DE reported gross profit of -$1.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What was MEDICINES CO /DE's operating income in fiscal 2018?
MEDICINES CO /DE reported operating income of -$191.4 million for fiscal 2018 (the year ended Dec 31, 2018), against -$665.1 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What was MEDICINES CO /DE's net income in fiscal 2018?
MEDICINES CO /DE reported net income of -$123.2 million for fiscal 2018 (the year ended Dec 31, 2018), against -$708.4 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What was MEDICINES CO /DE's cash from operating activities in fiscal 2018?
MEDICINES CO /DE reported cash from operating activities of -$261.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$368.3 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What was MEDICINES CO /DE's free cash flow in fiscal 2018?
MEDICINES CO /DE reported free cash flow of -$261.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$372.8 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What are MEDICINES CO /DE's total assets?
As of Dec 31, 2018, MEDICINES CO /DE reported total assets of $841.7 million, against $873 million a year earlier (-3.6%). Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What are MEDICINES CO /DE's total liabilities?
As of Dec 31, 2018, MEDICINES CO /DE reported total liabilities of $864 million, against $848.1 million a year earlier (+1.9%). Source: the 10-K filed with the SEC on Feb 27, 2019. SEC
What are MEDICINES CO /DE's cash and cash equivalents?
As of Dec 31, 2018, MEDICINES CO /DE reported cash and cash equivalents of $238.3 million, against $151.4 million a year earlier (+57.4%). Source: the 10-K filed with the SEC on Feb 27, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1113481&period_type=annual&limit=5"

Information only, not investment advice.